Cancer Incidence and Mortality for All Sites of Cancer, Nassau County, 2005-2009

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males Females Males Females
Average Annual Cases Rate per 100,000 Males 95% CI (+/-) Average Annual Cases Rate per 100,000 Females 95% CI (+/-) Average Annual Deaths Rate per 100,000 Males 95% CI (+/-) Average Annual Deaths Rate per 100,000 Females 95% CI (+/-)
All Invasive Malignant Tumors 4221.4 588.0 8.0 4224.2 475.5 6.6 1243.4 176.4 4.4 1313.0 137.2 3.4
Oral cavity and pharynx
All Oral cavity and pharynx 94.4 12.8 1.2 55.4 6.3 0.8 21.2 2.9 0.6 9.2 0.9 0.3
Lip 4.4 0.6 0.3 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0
Tongue 27.8 3.8 0.6 17.4 2.0 0.4 6.2 0.8 0.3 3.0 0.3 0.2
Salivary gland 14.2 2.0 0.5 10.6 1.3 0.4 3.4 0.5 0.2 1.6 0.1 0.1
Floor of mouth 5.8 0.8 0.3 3.2 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.0
Gum & other mouth 11.0 1.5 0.4 11.6 1.2 0.3 2.6 0.4 0.2 1.6 0.2 0.1
Nasopharynx 5.4 0.8 0.3 2.6 0.3 0.2 1.6 0.2 0.2 1.0 0.1 0.1
Tonsil 14.4 1.8 0.4 4.4 0.5 0.2 1.6 0.2 0.2 0.2 0.0 0.0
Oropharynx 3.6 0.5 0.2 1.4 0.1 0.1 1.2 0.2 0.1 0.2 0.0 0.0
Hypopharynx 6.8 0.9 0.3 2.6 0.3 0.2 0.4 0.1 0.1 0.4 0.1 0.1
Other buccal cavity and pharynx 1.0 0.1 0.1 0.8 0.1 0.1 4.0 0.6 0.2 1.2 0.1 0.1
Digestive system
All Digestive system 755.8 105.5 3.4 676.0 70.9 2.4 360.8 50.9 2.4 313.2 31.8 1.6
Esophagus 54.2 7.6 0.9 15.8 1.6 0.4 42.8 6.0 0.8 13.6 1.3 0.3
Stomach 67.2 9.4 1.0 49.8 5.4 0.7 29.6 4.1 0.7 29.6 3.1 0.5
Small intestine 19.4 2.6 0.5 19.8 2.2 0.4 2.2 0.3 0.2 3.0 0.3 0.2
Colorectal 368.8 51.7 2.4 382.8 39.9 1.8 125.0 18.0 1.4 126.0 12.7 1.0
Colon excluding rectum 257.0 36.3 2.0 286.4 29.5 1.6 105.0 15.1 1.3 108.6 11.0 0.9
Cecum 51.6 7.3 0.9 71.4 7.3 0.8            
Appendix 7.6 1.1 0.4 7.0 0.9 0.3            
Ascending colon 51.8 7.3 0.9 59.0 6.0 0.7            
Hepatic flexure 12.2 1.8 0.4 14.0 1.4 0.3            
Transverse colon 21.0 3.0 0.6 26.0 2.7 0.5            
Splenic flexure 10.0 1.4 0.4 8.4 0.9 0.3            
Descending colon 20.4 2.8 0.6 16.2 1.7 0.4            
Sigmoid colon 66.6 9.3 1.0 63.0 6.7 0.8            
Large intestine, NOS 15.8 2.3 0.5 21.4 2.1 0.4            
Rectum & rectosigmoid 111.8 15.5 1.3 96.4 10.4 0.9 20.0 2.8 0.6 17.4 1.7 0.4
Rectosigmoid junction 39.0 5.4 0.8 39.2 4.2 0.6            
Rectum 72.8 10.1 1.0 57.2 6.2 0.7            
Anus, anal canal & anorectum 8.4 1.1 0.3 9.4 1.1 0.3 1.0 0.1 0.1 1.4 0.1 0.1
Liver and intrahepatic bile duct 76.6 10.4 1.0 29.2 3.2 0.5 53.6 7.4 0.9 24.6 2.5 0.4
Liver 69.8 9.4 1.0 23.0 2.5 0.5 38.8 5.3 0.8 13.8 1.4 0.3
Intrahepatic bile duct 6.8 0.9 0.3 6.2 0.7 0.2 14.8 2.1 0.5 10.8 1.1 0.3
Gallbladder 11.8 1.7 0.4 18.0 1.9 0.4 6.4 0.9 0.3 11.6 1.2 0.3
Other biliary 21.6 3.0 0.6 18.4 1.9 0.4 4.0 0.6 0.2 3.2 0.3 0.1
Pancreas 120.8 16.9 1.4 112.8 11.5 1.0 94.4 13.2 1.2 95.0 9.7 0.9
Retroperitoneum 3.6 0.5 0.2 3.0 0.3 0.2 0.6 0.1 0.1 0.6 0.1 0.1
Peritoneum, omentum & mesentery 0.4 0.0 0.1 15.0 1.7 0.4 0.4 0.1 0.1 2.8 0.3 0.2
Other digestive organs 3.0 0.4 0.2 2.0 0.2 0.1 0.8 0.1 0.1 1.8 0.2 0.1
Respiratory system
All Respiratory system 507.6 71.5 2.8 533.4 57.3 2.2 325.8 46.0 2.3 315.8 33.2 1.7
Nasal cavity, middle ear & sinuses 4.8 0.7 0.3 2.8 0.3 0.2 0.6 0.1 0.1 1.8 0.2 0.1
Larynx 39.8 5.5 0.8 12.0 1.3 0.3 9.4 1.3 0.4 3.0 0.3 0.2
Lung and bronchus 460.2 64.9 2.7 517.8 55.6 2.2 314.6 44.4 2.2 310.8 32.6 1.6
Pleura 0.2 0.0 0.0 0.2 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0
Trachea, mediastinum, other respiratory 2.6 0.4 0.2 0.6 0.1 0.1 0.4 0.1 0.1 0.2 0.0 0.0
Soft Tissue, Bone, and Skin
Bones & joints 7.6 1.1 0.4 6.8 0.9 0.3 2.2 0.4 0.2 3.8 0.5 0.2
Soft tissue (including heart) 31.6 4.5 0.7 24.8 3.1 0.6 10.4 1.4 0.4 8.4 0.9 0.3
Skin~ 241.6 33.9 1.9 172.2 20.4 1.4 30.4 4.3 0.7 21.4 2.3 0.5
Melanoma of the skin 225.4 31.6 1.9 158.6 18.9 1.4 26.2 3.7 0.6 18.2 2.0 0.4
Breast
Breast 13.8 2.0 0.5 1265.2 146.0 3.7 2.4 0.4 0.2 202.8 21.8 1.4
Female genital system
All Female genital system       502.0 57.2 2.3       152.6 16.3 1.2
Cervix uteri       53.2 7.1 0.9       12.6 1.5 0.4
Corpus uterus and NOS       284.4 31.7 1.7       43.8 4.7 0.6
Ovary       132.8 15.0 1.2       88.8 9.4 0.9
Vagina       5.0 0.5 0.2       1.4 0.1 0.1
Vulva       17.6 1.9 0.4       5.4 0.5 0.2
Other female genital organs       9.0 1.0 0.3       0.6 0.1 0.1
Male genital system
All Male genital system 1304.0 178.4 4.4       125.6 18.4 1.4      
Prostate 1257.2 170.9 4.3       123.8 18.1 1.4      
Testis 40.4 6.5 0.9       1.0 0.1 0.1      
Penis 5.2 0.7 0.3       0.8 0.1 0.1      
Other male genital organs 1.2 0.2 0.1       0.0 0.0 0.0      
Urinary system
All Urinary system 529.4 73.9 2.8 231.0 24.8 1.5 87.4 12.4 1.2 41.6 4.1 0.6
Urinary bladder (including in situ) 329.8 46.3 2.3 123.2 12.8 1.0 51.0 7.4 0.9 19.4 1.9 0.4
Kidney and renal pelvis 187.6 25.9 1.7 102.6 11.5 1.0 34.2 4.8 0.7 20.2 2.0 0.4
Ureter 7.0 1.0 0.3 4.2 0.4 0.2 1.0 0.1 0.1 0.6 0.1 0.1
Other urinary organs 5.0 0.7 0.3 1.0 0.1 0.1 1.2 0.2 0.1 1.4 0.1 0.1
Eye & orbit
Eye & orbit 8.0 1.1 0.3 8.6 1.0 0.3 0.2 0.0 0.1 0.6 0.1 0.1
Brain and central nervous system
All Brain / other nervous system (all behaviors) 120.6 17.5 1.4 182.2 21.3 1.4 34.0 4.8 0.7 38.4 4.3 0.6
Malignant brain / other nervous system 52.4 7.7 0.9 50.0 6.1 0.8 27.2 3.8 0.6 29.4 3.3 0.6
Malignant brain 49.8 7.2 0.9 46.8 5.7 0.8            
Malignant other nervous system 2.6 0.4 0.2 3.2 0.4 0.2            
Benign brain / other nervous system* 68.2 9.8 1.1 132.2 15.2 1.2 6.8 1.0 0.3 9.0 0.9 0.3
Benign brain 8.8 1.3 0.4 9.0 1.2 0.4            
Benign other nervous system 59.4 8.5 1.0 123.2 14.0 1.1            
Endocrine system
All Endocrine system 76.6 10.8 1.1 194.8 26.1 1.7 6.4 0.9 0.3 8.4 0.9 0.3
Thyroid 68.0 9.6 1.0 186.8 25.1 1.7 4.2 0.6 0.2 4.4 0.5 0.2
Other endocrine (including thymus) 8.6 1.2 0.4 8.0 1.0 0.3 2.2 0.3 0.2 4.0 0.5 0.2
Lymphomas
All Lymphomas 227.8 32.3 1.9 201.0 23.1 1.5 57.2 8.1 0.9 46.4 4.7 0.6
Hodgkin lymphoma 28.4 4.1 0.7 21.0 3.0 0.6 3.4 0.5 0.2 2.8 0.4 0.2
Non-Hodgkin lymphomas 199.4 28.2 1.8 180.0 20.0 1.3 53.8 7.6 0.9 43.6 4.3 0.6
Multiple myeloma
All Multiple myeloma 64.0 8.9 1.0 54.2 5.7 0.7 30.0 4.2 0.7 25.0 2.6 0.5
Leukemias
All Leukemias 135.0 19.1 1.5 93.0 10.5 1.0 68.4 9.9 1.1 46.4 4.8 0.6
Lymphocytic leukemias 73.8 10.4 1.1 50.4 5.8 0.7 22.8 3.3 0.6 14.4 1.4 0.3
Acute lymphocytic leukemia 14.0 2.1 0.5 10.6 1.6 0.4 6.0 0.9 0.3 3.0 0.4 0.2
Chronic lymphocytic leukemia 54.0 7.5 0.9 38.0 4.0 0.6 16.0 2.3 0.5 10.6 1.0 0.3
Other lymphocytic leukemias 5.8 0.8 0.3 1.8 0.2 0.1 0.8 0.1 0.1 0.8 0.1 0.1
Myeloid and monocytic leukemias 57.0 8.1 1.0 38.6 4.3 0.6 34.2 4.9 0.7 23.8 2.5 0.5
Acute myeloid leukemia 38.2 5.4 0.8 26.2 2.9 0.5 30.2 4.3 0.7 22.0 2.3 0.4
Acute monocytic leukemia 1.2 0.2 0.1 1.2 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0
Chronic myeloid leukemia 15.8 2.3 0.5 10.0 1.1 0.3 2.4 0.4 0.2 1.0 0.1 0.1
Other myeloid/monocytic leukemias 1.8 0.3 0.2 1.2 0.1 0.1 1.4 0.2 0.2 0.8 0.1 0.1
Other leukemias 4.2 0.6 0.3 4.0 0.4 0.2 11.4 1.7 0.4 8.2 0.8 0.3
Other acute leukemias 1.0 0.1 0.1 1.8 0.2 0.1 4.8 0.7 0.3 4.2 0.4 0.2
Aleukemic, subacute, leukemia NOS 3.2 0.5 0.2 2.2 0.2 0.1 6.6 1.0 0.3 4.0 0.4 0.2
Mesothelioma
Mesothelioma 15.0 2.1 0.5 3.8 0.4 0.2            
Kaposi Sarcoma
Kaposi Sarcoma 7.2 1.1 0.4 1.0 0.1 0.1            
Myelodysplastic Syndromes
Myelodysplastic Syndromes 48.8 7.0 0.9 35.4 3.5 0.5            
Chronic Myeloproliferative Disorders^
Chronic Myeloproliferative Disorders^ 27.8 3.9 0.7 29.8 3.2 0.5            
Ill defined and unspecified sites
Ill defined and unspecified sites 73.0 10.3 1.1 85.8 8.6 0.8 87.4 12.4 1.2 88.0 8.8 0.8

Key

Symbol Meaning
~ Incidence of skin cancer excludes basal and squamous cell cancers.
* Brain and other nervous system tumors with benign or uncertain behaviors are not included in the total for all invasive malignant tumors.
^ Tumors with a histology of 9963 or 9964 are included under Aleukemic, Subacute, Leukemia NOS, instead of Chronic Myeloproliferative Disorder.

Notes

  • Incidence data are provisional, November 2011.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.